International non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://xitter.cf/t.co/666r8GVfmr
Switzerland and Worldwide
Joined February 2011
- Tweets12.6K
- Following2.9K
- Followers24.7K
- Likes12.6K
Congratulations to our Continental Lead for Africa, @EADirectorDNDi, on his induction into the US @theNAMedicine this weekend! He’s recognized for his work on drug-resistant food and waterborne infections and vaccine programmes in sub-Saharan Africa.
@KEMRI_Kenya
Drugs for Neglected Diseases initiative retweeted
Applications are now open for the 2026 cohort of the MSF Without Borders Media Fellowship.
Médecins Sans Frontières (MSF) South Asia, in partnership with Drugs for Neglected Diseases initiative (@DNDi), is inviting journalists, photographers, filmmakers, digital media influencers, and newsroom editors from across South Asia to submit proposals for the 2026 cohort of the Without Borders Media Fellowship.
The fellowship is designed to support humanitarian and health-related journalistic reporting and to use scientific storytelling to draw attention to emerging local and cross-border issues across the South Asia region.
1. MSF General Grant
Open to applicants across South Asia, with reporting proposals on themes including:
Tuberculosis, HIV, Health Impact of Climate Change, Women’s Health, Impact of Caste on Health, Health Misinformation, Antimicrobial Resistance (AMR), Digital/Mobile Health, Access to Healthcare in Conflict Settings, Migration and Displacement/Refugees, and Mental Health.
2. MSF-DNDi Grant on Neglected Tropical Diseases (NTDs)
Focused on diseases such as lymphatic filariasis (hathipaon), visceral leishmaniasis (kala azar), mycetoma, dengue, and snakebite.
This category is only open to applicants from India, Nepal, Bangladesh, and Sri Lanka.
Apply to join a fellowship that supports rigorous, compassionate, field-based reporting on some of the most urgent health and humanitarian issues in South Asia.
Apply now: msfsouthasia.org/without-bor…
#WithoutBordersMediaFellowship #MSF #PublicHealth #MediaFellowship
Acoziborole has shown promise as a single-dose treatment for gambiense sleeping sickness. This study in @PLOSNTDs suggests it could be equally effective against rhodesiense sleeping sickness, an important step toward eliminating the disease.
journals.plos.org/plosntds/a…
How can PDPs help shape the future of global health?
We’re co-hosting a session at #WHS2026 with partners to discuss how our model can deliver accessible health innovations in a changing global health & funding landscape.
📅 11 Oct, 16:00–17:30 CEST
youtube.com/live/9wEMJXMFhlg
Drugs for Neglected Diseases initiative retweeted
✈️GHTC ED @KristieMikus is heading to Berlin next week for #WHS! We look forward to engaging with you all - including at an event focused on PDPs with @MedsforMalaria, @Pop_Council, @invectorcontrol, @TBAlliance, @dsw_de, @PATHtweets, & @DNDi.
See more! worldhealthsummit.org/sessio…
India supplies around 20% of the world’s generic medicines & is one of the largest vaccine manufacturers globally. But could it play a leading role in developing tomorrow's medicines?
Read our Asia Continental Lead @sanjayssarin's op-ed in @businessline
thehindubusinessline.com/spe…
Drugs for Neglected Diseases initiative retweeted
@KNUSTGH and @KCCR_GH has launched a new drug discovery partnership with @DNDi to help develop better treatments for schistosomiasis, one of Africa's most widespread parasitic diseases.
Learn more here ⬇️
kccr-ghana.org/kccr-and-dndi…
Drugs for Neglected Diseases initiative retweeted
I’ll be speaking at the World Health Summit 2026 in Berlin.
📍 Workshop: Shaping the Global Health Architecture and Ending Diseases of Poverty
📅 11 October | 16:00–17:30
📌 Forum 2
#WHS2026 #GlobalHealth #Mycetoma #NTDs @DNDi
We're proud to be recognized as a Very High Performer in the 2026 Gender & Health Index by Global Health 50/50!
We remain committed to improving gender equity both inside our organization & through our work for patients affected by neglected diseases.
global5050.org/accountabilit…
Pleased to launch our first drug discovery partnership in Africa with @KNUSTGH🇬🇭. We’ll screen 100 compounds against #schistosomiasis parasites to develop the next gen of treatments while strengthening African-led R&D. Supported by @bmftr_bund.
dndi.org/press-releases/2026…
Patricia survived cryptococcal meningitis, but still lives with its consequences: the loss of her sight.
This disease is preventable & treatable, yet it remains one of the leading causes of death among people living with advanced HIV.
#WorldMeningitisDay
youtu.be/ISfRm9rjyc0
Who gets included in clinical trials matters because the treatments we develop need to reflect the needs and realities of the people who will use them.
👉@WHO is seeking input on improving the inclusion of underrepresented populations in clinical trials: extranet.who.int/dataformv6/…
🌍 But dengue is not just a challenge for Bangladesh. Climate change & urbanization affect where & when outbreaks occur.
There's still no specific treatment for dengue. With millions at risk worldwide, developing one is an urgent global health priority.
straitstimes.com/asia/south-…
🌍 Getting ready for #WHS2026!
On 11 Oct, Dr Borna Nyaoke-Anoke, our Head of Mycetoma, will speak at a session to discuss the role of product development partnerships (PDPs) in advancing health equity.
🔗 Join us: worldhealthsummit.org/sessio…
@WorldHealthSmt
Drugs for Neglected Diseases initiative retweeted
🤝 GARDP and the @DNDi are pleased to announce the support of the Foundation for the Adaptation of International Geneva to strengthen our collaboration in Geneva.
As global health organizations face growing challenges and increasing pressure on resources, reinforcing how we work together to sustain impact is needed.
Thanks to this support, we will:
👉 Strengthen shared capabilities across pharmaceutical development, human resources, environmental and social responsibility, health and safety, and legal cooperation, allowing both organizations to operate more efficiently and resiliently.
👉 Direct more resources towards what matters most, developing and ensuring access to treatments for drug-resistant infections and neglected diseases.
👉 Explore how our collaborative model could benefit other international health organizations based in Geneva.
By sharing expertise, resources, and systems, independent organizations can strengthen their impact while preserving their distinct missions and scientific mandates.
🙏 We are grateful to the Foundation for the Adaptation of International Geneva for its commitment to strengthening collaboration across International Geneva.
#GlobalHealth #InternationalGeneva #NeglectedDiseases #AMR #AccessToMedicines
At #UNGA81, our Senior Policy Advocacy Manager Rachael Crockett explains why Article 9.5 of the @WHO Pandemic Agreement could be a game changer for equitable access.
🔗 Read our intervention at UNGA: dndi.org/statements/2026/dnd…
What will it take to deliver therapeutics, diagnostics, & vaccines when the next outbreak hits?
At #UNGA81, Rachel Cohen highlighted 3 key priorities for pandemic R&D and access.
Read the @devex article: devex.com/news/sponsored/del…
Watch the recording: youtube.com/watch?v=ZZ6jJj5M…